Skip to main content
Erschienen in: Acta Neurologica Belgica 3/2020

05.06.2018 | Original Article

Simulating glioblastoma growth consisting both visible and invisible parts of the tumor using a diffusion–reaction model followed by resection and radiotherapy

verfasst von: Navid Moshtaghi-Kashanian, Hanieh Niroomand-Oscuii, Nargess Meghdadi

Erschienen in: Acta Neurologica Belgica | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Glioblastoma is known to be among one of the deadliest brain tumors in the world today. There have been major improvements in the detection of cancerous cells in the twenty-first century. However, the threshold of detection of these cancerous cells varies in different scanning techniques such as magnetic resonance imaging (MRI) and computed tomography (CT). The growth of these tumors and different treatments have been modeled to assist medical experts in better predictions of the related tumor growth and in the selection of more accurate treatments. In clinical terms the tumor consisted of two parts known as the visible part, which is the part of the tumor that is above the threshold of the detecting device and the invisible part, which is below the detecting threshold. In this study, the common reaction–diffusion model of tumor growth is used to simulate the growth of the glioblastoma tumor. Also resection and radiotherapy have been modeled as methods to prevent the growth of the tumor. The results demonstrate that although the selected treatments were effective in reducing the number of cancerous cells to under the threshold of detection, they did not eliminate all cancerous cells and if no further treatments were applied, the cancerous cells would spread and become malignant again. Although previous studies have suggested that the ratio of proliferation to diffusion could describe the malignancy of the tumor, this study in addition shows the importance of each of the coefficients regarding the malignancy of the tumor.
Literatur
1.
Zurück zum Zitat Swanson KR, Bridge C, Murray J, Alvord EC (2003) Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 216(1):1–10PubMed Swanson KR, Bridge C, Murray J, Alvord EC (2003) Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 216(1):1–10PubMed
2.
Zurück zum Zitat Swanson KR, Alvord EC Jr, Murray J (2002) Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery. Acta Biotheor 50(4):223–237PubMed Swanson KR, Alvord EC Jr, Murray J (2002) Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery. Acta Biotheor 50(4):223–237PubMed
3.
Zurück zum Zitat Gevertz JL, Torquato S (2006) Modeling the effects of vasculature evolution on early brain tumor growth. J Theor Biol 243(4):517–531PubMed Gevertz JL, Torquato S (2006) Modeling the effects of vasculature evolution on early brain tumor growth. J Theor Biol 243(4):517–531PubMed
4.
Zurück zum Zitat Harpold HL, Alvord EC, Swanson KR (2007) The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol 66(1):1–9PubMed Harpold HL, Alvord EC, Swanson KR (2007) The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol 66(1):1–9PubMed
5.
Zurück zum Zitat Eikenberry SE, Sankar T, Preul M, Kostelich E, Thalhauser C, Kuang Y (2009) Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model. Cell Prolif 42(4):511–528PubMedPubMedCentral Eikenberry SE, Sankar T, Preul M, Kostelich E, Thalhauser C, Kuang Y (2009) Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model. Cell Prolif 42(4):511–528PubMedPubMedCentral
6.
Zurück zum Zitat Iwamoto F, Abrey L, Beal K, Gutin P, Rosenblum M, Reuter V, DeAngelis L, Lassman A (2009) Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology 73(15):1200–1206PubMedPubMedCentral Iwamoto F, Abrey L, Beal K, Gutin P, Rosenblum M, Reuter V, DeAngelis L, Lassman A (2009) Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology 73(15):1200–1206PubMedPubMedCentral
7.
Zurück zum Zitat Mahmoudi K, Hadjipanayis CG (2014) The application of magnetic nanoparticles for the treatment of brain tumors. Front Chem 2 Mahmoudi K, Hadjipanayis CG (2014) The application of magnetic nanoparticles for the treatment of brain tumors. Front Chem 2
8.
Zurück zum Zitat Hogea C, Davatzikos C, Biros G (2008) An image-driven parameter estimation problem for a reaction–diffusion glioma growth model with mass effects. J Math Biol 56(6):793–825PubMed Hogea C, Davatzikos C, Biros G (2008) An image-driven parameter estimation problem for a reaction–diffusion glioma growth model with mass effects. J Math Biol 56(6):793–825PubMed
9.
Zurück zum Zitat Meghdadi N, Soltani M, Niroomand-Oscuii H, Ghalichi F (2016) Image based modeling of tumor growth. Australas Phys Eng Sci Med 39(3):601–613PubMed Meghdadi N, Soltani M, Niroomand-Oscuii H, Ghalichi F (2016) Image based modeling of tumor growth. Australas Phys Eng Sci Med 39(3):601–613PubMed
10.
Zurück zum Zitat Fung LK, Shin M, Tyler B, Brem H, Saltzman WM (1996) Chemotherapeutic drugs released from polymers: distribution of 1, 3-bis (2-chloroethyl)-l-nitrosourea in the rat brain. Pharmaceut Res 13(5):671–682 Fung LK, Shin M, Tyler B, Brem H, Saltzman WM (1996) Chemotherapeutic drugs released from polymers: distribution of 1, 3-bis (2-chloroethyl)-l-nitrosourea in the rat brain. Pharmaceut Res 13(5):671–682
11.
Zurück zum Zitat Swanson K, Harpold H, Peacock D, Rockne R, Pennington C, Kilbride L, Grant R, Wardlaw J, Alvord E (2008) Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle. Clin Oncol 20(4):301–308 Swanson K, Harpold H, Peacock D, Rockne R, Pennington C, Kilbride L, Grant R, Wardlaw J, Alvord E (2008) Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle. Clin Oncol 20(4):301–308
12.
Zurück zum Zitat Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, Jusenius K, Wardlaw JM, Cloughesy T, Spence AM, Rockne R (2009) Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. Cancer Res 69(23):9133–9140PubMedPubMedCentral Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, Jusenius K, Wardlaw JM, Cloughesy T, Spence AM, Rockne R (2009) Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. Cancer Res 69(23):9133–9140PubMedPubMedCentral
13.
Zurück zum Zitat Murray JD (2001) Mathematical biology. II Spatial models and biomedical applications {Interdisciplinary Applied Mathematics V. 18}. Springer, New York Incorporated Murray JD (2001) Mathematical biology. II Spatial models and biomedical applications {Interdisciplinary Applied Mathematics V. 18}. Springer, New York Incorporated
14.
Zurück zum Zitat Murray JD (2002) Mathematical biology I: an introduction, vol 17 of interdisciplinary applied mathematics. Springer, New York, NY Murray JD (2002) Mathematical biology I: an introduction, vol 17 of interdisciplinary applied mathematics. Springer, New York, NY
15.
Zurück zum Zitat Swanson K, Rostomily R, Alvord E (2008) A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle. Br J Cancer 98(1):113–119PubMed Swanson K, Rostomily R, Alvord E (2008) A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle. Br J Cancer 98(1):113–119PubMed
16.
Zurück zum Zitat Mandonnet E, Broët P, Swanson K, Carpentier A, Delattre J, Capelle L (2002) Linear growth of mean tumor diameter in low grade gliomas. Neurology 58(Suppl 3):A13 Mandonnet E, Broët P, Swanson K, Carpentier A, Delattre J, Capelle L (2002) Linear growth of mean tumor diameter in low grade gliomas. Neurology 58(Suppl 3):A13
17.
Zurück zum Zitat Rockne R, Rockhill J, Mrugala M, Spence A, Kalet I, Hendrickson K, Lai A, Cloughesy T, Alvord E Jr, Swanson K (2010) Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach. Phys Med Biol 55(12):3271PubMedPubMedCentral Rockne R, Rockhill J, Mrugala M, Spence A, Kalet I, Hendrickson K, Lai A, Cloughesy T, Alvord E Jr, Swanson K (2010) Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach. Phys Med Biol 55(12):3271PubMedPubMedCentral
18.
Zurück zum Zitat Swanson KR, Rockne RC, Claridge J, Chaplain MA, Alvord EC, Anderson AR (2011) Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology. Cancer Res 71(24):7366–7375PubMedPubMedCentral Swanson KR, Rockne RC, Claridge J, Chaplain MA, Alvord EC, Anderson AR (2011) Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology. Cancer Res 71(24):7366–7375PubMedPubMedCentral
19.
Zurück zum Zitat Rockne R, Alvord E Jr, Rockhill J, Swanson K (2009) A mathematical model for brain tumor response to radiation therapy. J Math Biol 58(4–5):561–578PubMed Rockne R, Alvord E Jr, Rockhill J, Swanson K (2009) A mathematical model for brain tumor response to radiation therapy. J Math Biol 58(4–5):561–578PubMed
20.
Zurück zum Zitat Hall EJ, Giaccia AJ (2006) Radiobiology for the radiologist. Lippincott Williams & Wilkins Hall EJ, Giaccia AJ (2006) Radiobiology for the radiologist. Lippincott Williams & Wilkins
21.
Zurück zum Zitat Bashir R, Hochberg F, Oot R (1988) Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery 23(1):27–30PubMed Bashir R, Hochberg F, Oot R (1988) Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery 23(1):27–30PubMed
Metadaten
Titel
Simulating glioblastoma growth consisting both visible and invisible parts of the tumor using a diffusion–reaction model followed by resection and radiotherapy
verfasst von
Navid Moshtaghi-Kashanian
Hanieh Niroomand-Oscuii
Nargess Meghdadi
Publikationsdatum
05.06.2018
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 3/2020
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-018-0952-6

Weitere Artikel der Ausgabe 3/2020

Acta Neurologica Belgica 3/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.